Clinical Trial Update: Xanthohumol as an Adjuvant in the Treatment of Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Xanthohumol as an adjuvant therapy for septic shock, with recruitment ongoing; the study lists septic shock, pneumonia, and acu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Respiratory Distress Syndrome
• Septic Shock

Drugs mentioned

• Xanthohumol (Xanthohumol)

Snippet

Sponsor: Medical University of Lublin | Conditions: Septic Shock, Pneumonia | Phase 2 | Status: RECRUITING